Does Blue Shield of California Cover Mounjaro?
The verdict
Conditional on most plans
Blue Shield of California (distinct from Anthem Blue Cross of California) covers Mounjaro for type 2 diabetes with prior authorization across commercial, ACA, and Medicare Part D lines. Mounjaro is not covered for weight loss. Blue Shield restricts commercial weight-loss GLP-1s (Wegovy, Zepbound) to a BMI of 40 or higher plus enrollment in a documented weight-management program (2025) — and Medi-Cal (California Medicaid) excludes weight-loss GLP-1s effective January 1, 2026. The weight-loss tirzepatide product is Zepbound, with separate and highly restricted coverage. Verify tier on the Blue Shield of CA formulary.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Blue Shield of California using your member ID.
Key facts
Mounjaro (tirzepatide) is FDA-approved for type 2 diabetes only — not weight loss. The weight-loss tirzepatide product is Zepbound, a separate FDA approval.
FDA drug labeling, Mounjaro (tirzepatide) prescribing information
California Medi-Cal excluded weight-loss GLP-1s (Wegovy, Zepbound, Saxenda) effective January 1, 2026 — Mounjaro's diabetes coverage is unaffected.
California Department of Health Care Services (DHCS), Medi-Cal PDL update 2026
The 2026 Medicare Part D out-of-pocket cap is $2,100; most continuous Mounjaro users for diabetes reach the cap within 2–3 months and pay $0 for the rest of the year.
CMS.gov, Medicare Part D Redesign 2025–2026
Medicare vs. commercial coverage
Whether Blue Shield of California covers Mounjaro depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Part D covers Mounjaro for type 2 diabetes only — not weight loss — at a specialty or non-preferred tier with prior authorization. The 2026 out-of-pocket cap is $2,100; most continuous users reach it within 2–3 months and pay $0 for the rest of the year. The IRA-negotiated Medicare MFN price of $245/month begins mid-2026. Mounjaro is NOT included in the 2026 Medicare GLP-1 Bridge ($50/month, July 1, 2026 – Dec 31, 2027), which covers weight-loss-approved products only. Lilly savings card is not usable by Medicare beneficiaries. Verify your specific Blue Shield of CA Medicare plan formulary each year.
Commercial / Employer
Group & marketplace plans
Commercial and employer-sponsored Blue Shield of California plans cover Mounjaro for type 2 diabetes with prior authorization; off-label weight-loss use (diagnosis code E66.x) is denied. Blue Shield restricts commercial weight-loss GLP-1s (Wegovy, Zepbound) to BMI of 40 or higher plus a documented weight-management program (2025) — this is for the on-label weight-loss products, not Mounjaro. ACA/Individual plans cover Mounjaro for T2D with PA; weight-loss GLP-1s are restricted/excluded. Medi-Cal (California Medicaid, including Blue Shield Promise) excludes weight-loss GLP-1s effective January 1, 2026 — diabetes coverage for Mounjaro is unaffected. Commercially insured patients with coverage may pay as little as $25/month via the Lilly savings card (excludes government programs; expires 12/31/2026). Without coverage on a commercial plan, the card reduces cost to $499/month (max $647/month, up to 13 fills). Verify tier on the Blue Shield of CA formulary.
The 5 boxes you must tick to get approved
Commercial plans that will consider Mounjaro require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Mounjaro actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $1,300–$1,560/month retail (WAC ~$1,080). Lilly savings card: $499/month for commercially insured without coverage (max $647/month, up to 13 fills; expires 12/31/2026). Excludes all government programs.
List price with no coverage — before any manufacturer savings card.
With coverage
Varies by plan tier — verify on Blue Shield of CA formulary or member services. Commercially insured patients with coverage may pay as little as $25/month via the Lilly savings card.
Typical monthly copay once prior authorization is approved.
Bridge program
Lilly Mounjaro Savings Card: commercially insured patients with coverage as little as $25/mo; without coverage $499/mo (up to 13 fills, expires 12/31/2026). Not available to Medicare, Medicaid (Medi-Cal), Medicare Advantage, or government program beneficiaries.
Reduced copay through the assistance program, where eligible.
All figures are estimates; actual cost-share varies by plan tier, pharmacy, and deductible status. Confirm with Blue Shield of CA formulary or member services. Medicare Part D: 25% coinsurance after deductible until the $2,100 OOP cap; MFN $245/month mid-2026. Medi-Cal nominal.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Search the Blue Shield of California formulary
Visit the Blue Shield of California member portal and use the drug lookup tool to search for 'Mounjaro' or 'tirzepatide.' Confirm the tier, prior authorization requirement, and cost-share for your specific plan. Note: Blue Shield of California is a separate company from Anthem Blue Cross of California — confirm you are using the correct plan's formulary.
- 2
Have your prescriber prepare the prior authorization
Your prescriber will need to document your confirmed T2D diagnosis (ICD-10 E11.x), A1c of 6.5% or higher within about 90 days, and a trial or failure of metformin. Note that Blue Shield's weight-loss GLP-1 PA criteria (BMI 40 plus program enrollment) are separate from and more restrictive than the diabetes PA criteria — a T2D diagnosis is the required pathway for Mounjaro.
- 3
For Medi-Cal, confirm diabetes coverage is unaffected by the 2026 weight-loss exclusion
Medi-Cal (California Medicaid) excluded weight-loss GLP-1s effective January 1, 2026. This applies to the on-label weight-loss products (Wegovy, Zepbound, Saxenda) — it does not affect Mounjaro's diabetes coverage. If you are on Medi-Cal through Blue Shield Promise, Mounjaro for type 2 diabetes remains available with PA. Confirm on the Medi-Cal PDL or with Blue Shield Promise member services.
Options if Blue Shield of California won't cover Mounjaro
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Ozempic (semaglutide)
FDA-approved for type 2 diabetes. Covered with PA across Blue Shield commercial and Medi-Cal plans; often placed ahead of Mounjaro in step-therapy sequences.
Trulicity (dulaglutide)
FDA-approved for T2D. GLP-1 alternative; often preferred tier with a lower list price than Mounjaro. Verify on Blue Shield of CA formulary.
Jardiance (empagliflozin) or Farxiga (dapagliflozin)
SGLT2 inhibitors approved for T2D with cardiovascular and renal benefits. May be part of step-therapy before GLP-1 approval on Blue Shield of CA plans.
Zepbound (tirzepatide) — weight loss only, highly restricted
Same molecule as Mounjaro but FDA-approved for chronic weight management. Blue Shield restricts commercial weight-loss GLP-1s to BMI 40 plus a program (2025). Medi-Cal excludes weight-loss GLP-1s from 1/1/2026. Zepbound and Mounjaro have completely separate PA pathways and coverage outcomes.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. Blue Shield of California does not cover Mounjaro for weight loss. Mounjaro is FDA-approved for type 2 diabetes only, and off-label weight-loss prescriptions are denied. Blue Shield restricts commercial weight-loss GLP-1s (Wegovy, Zepbound) to BMI of 40 or higher plus a documented program — and Medi-Cal excludes weight-loss GLP-1s from January 1, 2026. The weight-loss tirzepatide product is Zepbound, with separate and highly restricted coverage.
No. California Medi-Cal excluded weight-loss GLP-1s (Wegovy, Zepbound, Saxenda) effective January 1, 2026. This applies to the on-label weight-loss products — it does not affect Mounjaro's diabetes coverage under Medi-Cal. Enrollees on Medi-Cal through Blue Shield Promise who have type 2 diabetes can still access Mounjaro with prior authorization at nominal cost-share.
No. Blue Shield of California and Anthem Blue Cross of California are separate companies with different formularies, PA criteria, and plan designs. Blue Shield of California is a nonprofit insurer; Anthem Blue Cross of California is part of Elevance Health (formerly Anthem). If you have a Blue Shield card, confirm you are using Blue Shield of California's formulary tools, not Anthem's.
Yes, if you have commercial Blue Shield of California coverage and Mounjaro is covered on your plan, you may pay as little as $25/month via the Lilly savings card. Without commercial coverage, the card reduces cost to $499/month (max $647/month, up to 13 fills, expires 12/31/2026). The card is not available to Medicare Part D, Medicare Advantage, Medi-Cal, or any government program beneficiaries.
No. The 2026 Medicare GLP-1 Bridge ($50/month copay, July 1, 2026 – December 31, 2027) covers weight-loss-approved products only — Wegovy, Foundayo, and the Zepbound KwikPen. Mounjaro is excluded because it is a diabetes drug. Medicare covers Mounjaro for type 2 diabetes under standard Part D with prior authorization, specialty-tier cost-share, and the $2,100 annual OOP cap.
Related Articles
Does Blue Cross Blue Shield of Michigan Cover Mounjaro? | Curex
BCBS of Michigan covers Mounjaro for type 2 diabetes with PA, not weight loss. Zepbound weight-loss exclusion upheld by MI DIFS in 2025.
Read moreDoes Blue Cross Blue Shield of Minnesota Cover Mounjaro? 2026 | Curex
BCBS of Minnesota covers Mounjaro for type 2 diabetes with PA — not weight loss. MN Medicaid covers weight-loss GLP-1s for Zepbound, not Mounjaro.
Read moreDoes Blue Cross Blue Shield of Arizona Cover Mounjaro? | Curex
BCBS of Arizona covers Mounjaro for type 2 diabetes with prior auth — not weight loss. AZ Medicaid covers Wegovy for weight loss, but not Mounjaro.
Read moreDoes BCBS of North Carolina Cover Mounjaro? 2026 | Curex
BCBS NC covers Mounjaro for type 2 diabetes with prior auth — not weight loss. The NC Medicaid weight-loss GLP-1 churn never affected Mounjaro.
Read moreDoes Blue Cross Blue Shield of Texas Cover Mounjaro? 2026 | Curex
BCBS of Texas covers Mounjaro for type 2 diabetes with prior auth — not weight loss. The weight-loss tirzepatide is Zepbound, covered separately.
Read moreDoes Blue Cross Blue Shield of Illinois Cover Mounjaro? HCSC 2026 | Curex
BCBS of Illinois (HCSC) covers Mounjaro for type 2 diabetes with PA — not weight loss. IL Medicaid covers T2D but excludes weight-loss GLP-1s.
Read moreInsurance covers Mounjaro only for diabetes — for weight loss, here's a path that skips insurance
Blue Shield of California covers Mounjaro for diabetes only, not weight loss — its weight-loss GLP-1 coverage is BMI 40-restricted, and Medi-Cal excludes weight-loss GLP-1s from 1/1/2026. For patients who want tirzepatide access without insurance, compounded tirzepatide from $149/mo (and compounded semaglutide from $49/mo) is available at getcurex.com/cl/glp — no insurance required, no prior authorization. This is compounded tirzepatide and is not the same medication as Mounjaro or Zepbound. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Mounjaro and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Blue Shield of California before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Mounjaro and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.